← 返回

在 ATL 患者中,由 HLA-A02:01 限制性 CTLs 特异性针对 HTLV-1 所选择的基因表达和 TCR 氨基酸序列

英文原题:Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patients.

查看英文原题

Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patients.

PubMed 2023/06/15(内容时间) Br J Haematol Q2 · IF 3.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

成人T细胞白血病/淋巴瘤(ATL)是一种侵袭性外周T细胞恶性肿瘤,由人T细胞嗜淋巴病毒1型(HTLV-1)引起。Tax是HTLV-1最重要的调节蛋白。

本研究旨在揭示HLA-A*02:01限制性Tax₁₁₋₁₉特异性细胞毒性T细胞(Tax-CTL)的T细胞受体(TCR)β链和α链互补决定区3(CDR3)的独特氨基酸序列(AA)。研究采用SMARTer技术和新一代测序(NGS)方法评估Tax-CTL基因表达谱(GEP)。Tax-CTL似乎为寡克隆,其基因组成存在偏倚。几乎所有患者的TCRα CDR3中均观察到独特的“DSWGK”基序,TCRβ CDR3中则观察到“LAG”基序。携带“LAG”基序并具有BV28的Tax-CTL克隆,其结合评分高于不具备其中任一特征的克隆;较高结合评分还与更长生存期相关。由单细胞建立的Tax-CTL克隆可杀伤经Tax肽负载的HLA-A2⁺ T2细胞系。Tax-CTL基因表达谱显示,长期生存且病情稳定的患者保留了较完整的免疫应答相关基因。

本研究的方法和结果有助于更好理解ATL免疫,并可支持未来过继性T细胞治疗的临床应用研究。

展开英文摘要原文

Adult T-cell leukaemia/lymphoma (ATL) is an aggressive malignancy of peripheral T cells caused by human T-cell lymphotropic virus type-1 (HTLV-1). Tax is the most important regulatory protein for HTLV-1.

We aimed to reveal a unique amino acid sequence (AA) of complementarity-determining region 3 (CDR3) of the T-cell receptor (TCR)β and TCRα chains of HLA-A*02:01-restricted Tax 11-19 -specific cytotoxic T cells (Tax-CTLs). The gene expression profiles (GEP) of Tax-CTLs were assessed by the next-generation sequence (NGS) method with SMARTer technology. Tax-CTLs seemed to be oligoclonal, and their gene compositions were skewed. The unique motifs of 'DSWGK' in TCRα and 'LAG' in TCRβ at CDR3 were observed in almost all patients.

Tax-CTL clones harbouring the 'LAG' motif with BV28 had a higher binding score than those without either of them, besides a higher binding score associated with longer survival. Tax-CTLs established from a single cell showed killing activities against Tax-peptide-pulsed HLA-A2 + T2 cell lines.

GEP of Tax-CTLs revealed that genes associated with immune response activity were well preserved in long-term survivors with stable status. These methods and results can help us better understand immunity against ATL, and should contribute to future studies on the clinical application of adoptive T-cell therapies.

论文信息

作者
Kusuda M、Nakasone H、Yoshimura K、Okada Y、Tamaki M、Matsuoka A、Ishikawa T、Meno T
单位
Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.Japan
文献类型
非美国政府资助研究
期刊
British journal of haematology2023 Aug
原文标识
PubMed 37317804 · DOI 10.1111/bjh.18918